Here, we provide a brief review on the current understanding of the interplay between obesity, dyslipidemia and immunity. We also emphasize the advantages and shortcomings of numerous applicable ...

AZD-1705 is under clinical development by AstraZeneca and currently in Phase I for Dyslipidemia. According to GlobalData, Phase I drugs for Dyslipidemia have a 68% phase transition success rate (PTSR) ...

Streamline your presentation slideshow—and keep it consistent with the UB brand guidelines—by starting with one of our PowerPoint templates. Looking to include general information on some of the ...

Purpose: This study aims to assess the causal relationship between Obstructive Sleep Apnea (OSA), dyslipidemia, and osteoporosis using Mendelian Randomization (MR) techniques. Conclusion: The study ...

Click View Signatures. It will take you back to the PowerPoint presentation. On the right of the slide, you will see the Signature Pane. Hover the cursor over the signature inside the Signature ...

Four classes of lipid-lowering drugs are available: the 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors (the "statins"), the fibrates (gemfibrozil, clofibrate, and fenofibrate ...

Thus, via this simple way, you can choose to deliver your PowerPoint Presentation on 2 separate monitors. A post-graduate in Biotechnology, Hemant switched gears to writing about Microsoft ...